Sonos (SONO) closed the last trading session at $15.6, gaining 1.8% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $20 indicates a 28.2% upside potential.The average comprises three short-term price targets ranging from a low of $18.00 to a high of $21.00, with a standard deviation of $1.73. While the lowest estimate indicates an increase of 15.4% from the current price level, the ...

Key Takeaways ALAB expands AI connectivity portfolio with NVLink Fusion and Scorpio switch ramp-ups. ALAB sees addressable market topping $25B in five years, driven by copper and scale-up solutions. ALAB shares jumped 44.9% in six months; 2026 EPS estimate rose 4.36% to $2.39. Astera Labs (ALAB) is rapidly expanding its portfolio to address the growing demands of AI infrastructure and connectivity solutions. It benefits from strong demand for its PCIe solutions, which have been a major growth driver.The com ...

Investors in Southern Missouri Bancorp, Inc. (SMBC) need to pay close attention to the stock based on moves in the options market lately. That is because the Mar 20, 2026 $30 Put had some of the highest implied volatility of all equity options today.What is Implied Volatility?Implied volatility shows how much movement the market is expecting in the future. Options with high levels of implied volatility suggest that investors in the underlying stocks are expecting a big move in one direction or the other. It ...

Key Takeaways VMI's Q4 EPS rose 28% to $4.92 but missed estimates; revenues of $1.04B also fell short.Infrastructure sales grew 7%, led by 21% utility growth, while agriculture revenues fell nearly 20%.VMI guided FY26 sales of $4.2-$4.4B and EPS of $20.50-$23.50, with capex at $170-$200M.Valmont Industries, Inc. (VMI) reported fourth-quarter 2025 adjusted earnings of $4.92 per share, a roughly 28.1% rise from the year-ago quarter figure of $3.84. It missed the Zacks Consensus Estimate of $4.95.The company’s ...

Core Insights - Zacks Premium offers tools for investors to enhance their stock market strategies, including daily updates, research reports, and stock screens [1][2] Zacks Style Scores - Zacks Style Scores rate stocks based on value, growth, and momentum, providing complementary indicators to the Zacks Rank [2] - Stocks receive ratings from A to F, with A indicating the highest potential for outperforming the market [3] Value Score - The Value Style Score identifies attractive stocks using ratios like P/E, PEG, and Price/Sales, focusing on good prices before market recognition [3] Growth Score - The Growth Style Score assesses a company's financial strength and future outlook, considering projected and historical earnings, sales, and cash flow [4] Momentum Score - The Momentum Style Score helps investors capitalize on price trends, using metrics like one-week price changes and monthly earnings estimate changes [5] VGM Score - The VGM Score combines all three Style Scores, serving as a key indicator alongside the Zacks Rank to identify stocks with strong value, growth, and momentum [6] Zacks Rank - The Zacks Rank is a proprietary model that uses earnings estimate revisions to simplify portfolio building, with 1 (Strong Buy) stocks achieving an average annual return of +23.86% since 1988 [7][8] - There are over 800 top-rated stocks available, making it essential to utilize Style Scores for optimal stock selection [8] Stock to Watch: Delta Air Lines (DAL) - Delta Air Lines holds a 3 (Hold) Zacks Rank and a VGM Score of A, with a Momentum Style Score of B, indicating a 5% increase in shares over the past four weeks [11] - Analysts have revised DAL's earnings estimate upwards, with the Zacks Consensus Estimate rising by $0.09 to $7.22 per share, and an average earnings surprise of +7.9% [12]

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.Featuring daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, the research service can help you become a smarter, more self-assured investor.It also includes access to the Zacks Style Scores. What are the Zacks Style Scores? Developed alongsi ...

Key Takeaways Novo Nordisk secured EU approval for a 7.2 mg once-weekly Wegovy dose for obesity patients.STEP UP data showed 20.7% weight loss at 72 weeks with 7.2 mg vs 17.5% for 2.4 mg.About 33.2% on Wegovy 7.2 mg lost at least 25% weight. Safety matched the 2.4 mg profile.Novo Nordisk (NVO) announced that the European Commission (EC) has approved a new 7.2 mg once-weekly maintenance dose of Wegovy (semaglutide injection) for adults with obesity. This provides physicians with an additional treatment optio ...

Core Insights - Tempus AI, Inc. (TEM) is set to report its fourth-quarter 2025 results on February 24, with expectations of an 82.8% year-over-year revenue increase to $366.8 million [2][7] - The company reported an adjusted loss of 11 cents per share in the last quarter, which was better than the Zacks Consensus Estimate of a loss of 16 cents [1] - Tempus has seen a share price decline of 32.9% in the fourth quarter due to macroeconomic challenges, despite strong momentum from strategic acquisitions and product launches [3][7] Financial Performance - The Zacks Consensus Estimate for loss per share has remained unchanged at 2 cents over the past 30 days [2] - The company's earnings estimate revision trend shows consistent expectations for the current quarter and the next, with losses projected at -0.02 for Q4 and -0.13 for Q1 2026 [3] - In the previous quarter, Tempus achieved a gross profit improvement of 98.4% year-over-year, and adjusted EBITDA turned positive, indicating progress towards profitability [14] Market Position and Competitive Landscape - Tempus trades at a forward price-to-sales (P/S) ratio of 5.82X, which is above the industry average of 5.66X and higher than competitors like 10x Genomics (3.83X) and SOPHiA GENETICS (3.69X) [16] - The Zacks Medical Info Systems industry experienced a loss of 21.6% during the same period, while the S&P 500 gained 3.3% [4] Strategic Developments - Recent collaborations include a multi-year partnership with Whitehawk Therapeutics for oncology treatments and a selection by the Advanced Research Projects Agency for Health to provide testing services [8] - The Genomics segment is expected to show improvement due to growth in oncology testing and hereditary sequencing, while the Data and Services business is likely to benefit from strong demand for proprietary data licensing and AI solutions [9][10] - Tempus has enhanced its capabilities through the acquisition of Paige, an AI leader in digital pathology, and expanded its collaboration with Northwestern Medicine to integrate AI into clinical workflows [12] Future Outlook - The AI market is anticipated to grow rapidly, positioning Tempus to capitalize on emerging opportunities in healthcare [17] - Despite recent upsides, the company's premium valuation and lack of near-term profitability may limit immediate gains [18]

Core Insights - CNH Industrial reported fourth-quarter 2025 adjusted earnings per share (EPS) of 19 cents, an increase from 15 cents in the prior-year quarter, surpassing the Zacks Consensus Estimate of 11 cents [1] - Consolidated revenues rose 5.8% year over year to $5.16 billion, exceeding the Zacks Consensus Estimate of $5.02 billion [1] Segmental Performance - Agriculture segment net sales increased 5% year over year to $3.6 billion, driven by favorable price realization and positive foreign exchange impacts, beating the estimate of $3.41 billion [2] - Adjusted EBIT for the Agriculture segment was $233 million, down 5% year over year due to lower volumes and higher costs, but still above the estimate of $172.6 million; adjusted EBIT margin decreased to 6.5% from 7.2% [2] - Construction segment sales rose 19% year over year to $853 million, attributed to higher volume and favorable price realization in North America, surpassing the estimate of $810.3 million [3] - Adjusted EBIT for the Construction segment was $5 million, down 72% year over year due to increased production costs, with adjusted EBIT margin decreasing to 0.6% from 2.5% [3] - Financial Services segment revenues fell 6% to $700 million, missing the estimate of $770.4 million, while net income increased from $92 million to $109 million year over year [4] Financial Details - As of December 31, 2025, CNH Industrial had cash and cash equivalents of $2.58 billion, down from $3.19 billion a year earlier [5] - Total debt was $26.76 billion, a slight decrease from $26.88 billion as of December 31, 2024 [5] - Net cash provided by operating activities was $945 million, compared to $1.69 billion in the prior year [5] - Free cash outflow from industrial activities was $817 million, slightly improved from $848 million in the fourth quarter of 2024 [5] 2026 Guidance - For 2026, Agriculture sales are expected to decrease and remain flat at 5% year over year, with adjusted EBIT margin projected between 4.5-5.5% [6] - Construction segment sales are expected to remain flat year over year, with adjusted EBIT margin anticipated in the range of 1-2% [6] - Free cash flow from industrial activities is expected to be between $150-$350 million, with adjusted EPS projected between 35 cents and 45 cents, down from 55 cents in 2025 [7] Zacks Rank & Key Picks - CNH currently holds a Zacks Rank 4 (Sell) [8] - Other better-ranked stocks in the industrial product space include Kawasaki Heavy Industries, Kennametal, and Proto Labs, each with a Zacks Rank 1 (Strong Buy) [10]

Key Takeaways WPC shares gained 12.1% in three months, beating the industry growth of 7.4%.W.P. Carey posted Q4 2025 AFFO of $1.27, up 5% year over year on higher rents and investments.WPC holds 98% occupancy, a 12-year lease term and $2.2B liquidity to fund value-accretive deals.W.P. Carey (WPC) shares have rallied 12.1% over the past three months, outperforming the industry's upside of 7.4%.The company is poised to benefit from a high-quality, mission-critical, diversified portfolio of single-tenant, net- ...